Parkinson's disease is characterized by the progressive and selective loss of dopaminergic neurons in the substantia nigra. It has been postulated that endogenously formed CysDA (5-S-cysteinyldopamine) and its metabolites may be, in part, responsible for this selective neuronal loss, although the mechanisms by which they contribute to such neurotoxicity are not understood. Exposure of neurons in culture to CysDA caused cell injury, apparent 12–48 h post-exposure. A portion of the neuronal death induced by CysDA was preceded by a rapid uptake and intracellular oxidation of CysDA, leading to an acute and transient activation of ERK2 (extracellular-signal-regulated kinase 2) and caspase 8. The oxidation of CysDA also induced the activation of apoptosis signal-regulating kinase 1 via its de-phosphorylation at Ser967, the phosphorylation of JNK (c-Jun N-terminal kinase) and c-Jun (Ser73) as well as the activation of p38, caspase 3, caspase 8, caspase 7 and caspase 9. Concurrently, the inhibition of complex I by the dihydrobenzothiazine DHBT-1 [7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid], formed from the intracellular oxidation of CysDA, induces complex I inhibition and the subsequent release of cytochrome c which further potentiates pro-apoptotic mechanisms. Our data suggest a novel comprehensive mechanism for CysDA that may hold relevance for the selective neuronal loss observed in Parkinson's disease.
Skip Nav Destination
Article navigation
October 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
September 08 2014
The neurotoxicity of 5-S-cysteinyldopamine is mediated by the early activation of ERK1/2 followed by the subsequent activation of ASK1/JNK1/2 pro-apoptotic signalling
David Vauzour;
David Vauzour
1
*Molecular Nutrition Group, Centre for Integrative Neuroscience and Neurodynamics, School of Chemistry, Food and Pharmacy, University of Reading, Reading RG6 6AP, U.K.
Search for other works by this author on:
John T. Pinto;
John T. Pinto
†Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York, U.S.A.
Search for other works by this author on:
Arthur J. L. Cooper;
Arthur J. L. Cooper
†Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, New York, U.S.A.
Search for other works by this author on:
Jeremy P. E. Spencer
Jeremy P. E. Spencer
2
*Molecular Nutrition Group, Centre for Integrative Neuroscience and Neurodynamics, School of Chemistry, Food and Pharmacy, University of Reading, Reading RG6 6AP, U.K.
2To whom correspondence should be addressed (email j.p.e.spencer@reading.ac.uk).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
November 20 2013
Revision Received:
June 12 2014
Accepted:
June 18 2014
Accepted Manuscript online:
June 18 2014
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2014 Biochemical Society
2014
Biochem J (2014) 463 (1): 41–52.
Article history
Received:
November 20 2013
Revision Received:
June 12 2014
Accepted:
June 18 2014
Accepted Manuscript online:
June 18 2014
Citation
David Vauzour, John T. Pinto, Arthur J. L. Cooper, Jeremy P. E. Spencer; The neurotoxicity of 5-S-cysteinyldopamine is mediated by the early activation of ERK1/2 followed by the subsequent activation of ASK1/JNK1/2 pro-apoptotic signalling. Biochem J 1 October 2014; 463 (1): 41–52. doi: https://doi.org/10.1042/BJ20131519
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.